Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Condition:   Poliomyelitis Interventions:   Biological: Novel Oral Polio Vaccine Type 1 (nOPV1);   Biological: Novel Oral Polio Vaccine Type 3 (nOPV3);   Biological: Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1);   Biological: Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3) Sponsors:   PATH;   Bill and Melinda Gates Foundation;   Centers for Disease Control and Prevention;   Viroclinics Biosciences B.V.;   The Emmes Company, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials